| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |